Streetbeat News

Regulatory

TCNNF

TLRY

Recent analysis by Viridian Capital Advisors highlights significant differences in year-to-date performance between U.S. multi-state operators (MSOs) and Canadian licensed producers (LPs) in the cannabis sector. U.S. MSOs have seen an average return of 26.4%, while Canadian LPs have a modest 1.3%. However, excluding outliers like Trulieve Cannabis (TCNNF) and Tilray Brands (TLRY), the performance gap narrows significantly. The market's irrational behavior, influenced by regulatory changes and speculation, has led to volatility. Tilray faces challenges despite revenue gains, with a significant stock price drop after revising its financial outlook. Conversely, Trulieve's strategic success and market growth, especially with Germany's legalization and potential in Florida, position it for significant valuation increases.

Portfolio Pulse from Nicolás Jose Rodriguez

April 25, 2024 | 1:57 pm

MYNZ

Mainz Biomed announced positive topline results from a study evaluating novel mRNA biomarkers and a proprietary AI algorithm for colorectal cancer diagnostics, showing 92% sensitivity and 90% specificity. The study, which analyzed 690 subjects, including data from the ColoFuture and eAArly DETECT studies, demonstrated the potential to significantly improve early detection and treatment of pre-cancerous lesions.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 1:30 pm

BLK

MS

Morgan Stanley (NYSE:MS) is considering expanding its Bitcoin ETF offerings by allowing its 15,000 brokers to recommend them to clients, a shift from the current policy requiring client initiation. This move, still under refinement for risk management, reflects a broader trend among financial institutions cautiously embracing crypto, amidst varying approaches from firms like Merrill Lynch, Wells Fargo, and Vanguard. BlackRock Inc. (NYSE:BLK) and others have had Bitcoin ETF applications approved by the SEC, indicating a growing institutional interest in cryptocurrency investments.

Portfolio Pulse from Murtuza Merchant

April 25, 2024 | 1:23 pm

MULN

Mullen Automotive, Inc. (MULN) has received CARB certification for its 2025 Mullen THREE, Class 3 EV truck, enabling eligibility for state EV incentives and aligning with the ACF regulation for zero-emission vehicle purchases by state and local government fleets. This follows a previous certification for the 2024 model year. The certification could significantly boost Mullen's market presence in CARB-compliant states, offering substantial rebates and tax credits to lower the net cost of the Mullen THREE.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 1:22 pm

ACON

Aclarion, Inc. (NASDAQ: ACON, ACONW) announced its Nociscan solution will be used in the LIFEHAB trial in Norway to evaluate diagnosis and treatment of chronic low back pain. The trial compares lumbar interbody fusion surgery with multidisciplinary rehabilitation and aims to begin enrollment in Q2 2024. Nociscan, a SaaS platform, helps physicians identify the source of low back pain by quantifying chemical biomarkers. This marks an important step towards achieving successful reimbursement in Norway's single-payer health system.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 1:20 pm

NYCB

New York Community Bancorp's Board recommends shareholders to vote for several proposals, including a reverse stock split by a ratio of 1-3, increasing authorized shares, and approving executive compensation. Other proposals involve ratifying KPMG LLP as the independent auditor, amending the certificate of incorporation, waiving certain voting restrictions for affiliates of Liberty 77 Capital and Reverence Capital Partners, and approving a March 2024 capital raise in compliance with NYSE rules.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 1:19 pm

EIS

SPY

The United States along with 17 other nations have issued a call to Hamas for the release of hostages in Gaza, as reported by Reuters. This international plea highlights the ongoing geopolitical tensions in the region and could have implications on global markets.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 12:59 pm

CAT

Caterpillar anticipates ongoing weak economic conditions in Europe and a softening economy in the Asia-Pacific region, excluding China, according to Bloomberg.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 12:49 pm

ETN

Eaton has been awarded $26.6 million in federal tax credits to support its U.S. manufacturing and workforce training programs, aimed at advancing clean energy projects. This financial incentive is expected to bolster Eaton's position in the clean energy sector, enhancing its manufacturing capabilities and workforce skills in alignment with growing environmental sustainability trends.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 12:43 pm

APLM

Apollomics Inc. announced that its partner Avistone received approval from China's NMPA for vebreltinib as a treatment for gliomas with MET fusion gene. This marks vebreltinib as the first c-Met inhibitor approved for CNS tumors with c-Met alteration. The approval is based on the positive results of the FUGEN study, showing significant improvement in median overall survival for patients with ZM fusion-positive glioma. Apollomics retains rights outside China, with ongoing global studies showing similar promising results.

Portfolio Pulse from Benzinga Newsdesk

April 25, 2024 | 12:42 pm